Alonzo Weems to retire as Executive Vice President of Enterprise Risk Management, Chief Ethics and Compliance Officer: Eli Lilly
Indianapolis: Eli Lilly and Company has announced that Alonzo Weems, executive vice president of enterprise risk management and chief ethics and compliance officer, and a member of Lilly's Executive Committee, will retire after 27 years of service with the company, effective Dec. 31, 2024. Weems will continue to serve in his role while the company conducts an internal and external search for a chief ethics and compliance officer.
"Throughout his distinguished career, Alonzo has been a steadfast advocate for our company, providing strategic guidance to our global product development teams and major geographies worldwide," said David A. Ricks, Lilly's chair and CEO. "His collaborative approach with leaders has helped us achieve strong business performance while ensuring we uphold our values. As our chief ethics and compliance officer, Alonzo has championed the enhancement of our digital and data analytics capabilities and fortified our ethics program. His commitment to winning with integrity will leave a lasting legacy, and we thank him for his many years of service."
Weems began his Lilly career in 1997 as an attorney in the global medical and regulatory affairs legal group. Throughout his career, he has held important leadership roles, including general counsel for Lilly Canada, general counsel for Lilly USA and the Biomedicines and Diabetes business units, and vice president and deputy general counsel for the corporate legal functions prior to assuming his current role.
Read also: USFDA Advisory Committee to convene meeting to discuss on Eli Lilly Alzheimer's drug donanemab
